Skip to main content
TAKARA BIO INC. logo

TAKARA BIO INC. — Investor Relations & Filings

Ticker · 4974 ISIN · JP3460200003 LEI · 529900OUPLSGTCWC5447 T Manufacturing
Filings indexed 72 across all filing types
Latest filing 2018-08-10 Interim / Quarterly Rep…
Country JP Japan
Listing T 4974

Takara Bio Inc. is a biotechnology company that develops and supplies a wide range of high-quality, innovative tools for life science research. Its portfolio includes kits, reagents, and instruments that support investigations into gene discovery, regulation, and function. In addition to research products, the company provides comprehensive services, including single-cell analysis, stem cell services, and contract development and manufacturing (CDMO) services, particularly for the regenerative medicine sector. Takara Bio is also actively engaged in the development of gene-based therapies, conducting clinical trials for diseases such as cancer. The company's mission is to accelerate scientific discovery and contribute to human health through its advanced biotechnologies.

Recent filings

Filing Released Lang Actions
四半期報告書-第17期第1四半期(2018/04/01-2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Takara Bio Inc., covering the first quarter of the fiscal year ending March 31, 2019 (period from April 1, 2018, to June 30, 2018). It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement, as well as management's analysis of financial results. It is a formal regulatory filing under the Financial Instruments and Exchange Act of Japan. Therefore, it is classified as an Interim/Quarterly Report. Q1 2019
2018-08-10 Japanese
有価証券報告書-第16期(平成29年4月1日-平成30年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which translates to 'Annual Securities Report'. This is the standard, comprehensive annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains detailed financial statements, management discussion and analysis, and corporate information for the fiscal year ending March 31, 2018. Given the document's length, structure, and content, it corresponds to the '10-K' category in the provided schema. FY 2018
2018-06-28 Japanese
四半期報告書-第16期第3四半期(2017/10/01-2017/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Takara Bio Inc., covering the third quarter of the 16th fiscal year (April 1, 2017 to December 31, 2017). It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-02-09 Japanese
四半期報告書-第16期第2四半期(2017/07/01-2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Takara Bio Inc., covering the period from April 1, 2017, to September 30, 2017. It contains detailed financial statements, including the balance sheet, income statement, and cash flow analysis, as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2018
2017-11-10 Japanese
四半期報告書-第16期第1四半期(2017/04/01-2017/06/30)
Interim / Quarterly Report
2017-08-08 Japanese
有価証券報告書-第15期(2016/04/01-2017/03/31)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending March 31, 2017. It is a comprehensive annual filing submitted to the Kanto Local Finance Bureau. FY 2017
2017-06-29 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.